Today, the learned academies of Australia—representing over 3,000 of the nation’s best and most eminent scientists, researchers and other experts—come together to launch a searchable database of experts to help Australia tackle COVID-19. The database is championed by Australia’s Chief Scientist, Dr. Alan Finkel AO.
Australian Academy of Science Chief Executive, Ms. Anna-Maria Arabia, said the academies have created the COVID-19 Expert Database to provide a mechanism for governments, the business sector, the research sector and other decision-makers to easily access the expertise they need across many fields.
If you have expertise that can contribute to the national and global effort to tackle and recover from COVID-19, we call on you to register on this database.
All fields of expertise including science, technology, engineering, mathematics, health, humanities, arts, and social science are needed.
Australia and the world will benefit from quick access to expertise that provides insights into the COVID-19 pandemic and its scientific, health, social, cultural and economic implications.
The COVID-19 Expert Database is a public resource to inform decision-making in a fast-changing environment. By gathering the extraordinary expertise across our nation in one place, Australian academies offer governments and others an opportunity to consult experts and take actions that are evidence-informed and targeted.
Cross-disciplinary research has been the key to solving many of the world’s greatest challenges and tackling COVID-19 will be no different.”
Ms. Anna-Maria Arabia, Australian Academy of Science Chief Executive
The COVID-19 Expert Database, championed by Australia’s Chief Scientist, is a collaborative effort between Australia’s learned academies, the:
- Australian Academy of Science
- Australian Academy of Health and Medical Sciences
- Australian Academy of the Humanities
- Australian Council of Learned Academies
- Academy of the Social Sciences in Australia
- Australian Academy of Technology and Engineering.
Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients